What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Aventis
100%DGNews: Maintenance Bevacizumab Monotherapy Noninferior to Combination Therapy for Metastatic Colorectal Cancer: Presented at ESMO-GI
100%DGNews: Radiofrequency Ablation Improves Progression-Free Survival in Patients With Colorectal Liver Metastases: Presented at ESMO-GI
100%DGNews: No Increased Survival With Larotaxel Versus 5-FU in Patients With Advanced Pancreatic Cancer: Presented at ESMO-GI
100%DGNews: FOLFIRINOX Shows Promise as Treatment Option for Patients With Metastatic Pancreatic Cancer: Presented at ESMO-GI
100%DGNews: Addition of Aflibercept to Gemcitabine Does Not Prolong Survival in Patients With Metastatic Pancreatic Cancer: Presented at ESMO-GI
100%DGNews: Anti-Epileptic Drug Exposure During Pregnancy Increases Risk of Major Congenital Malformations: Presented at ECE
100%DGNews: Insulin Administration With Pen Device Improves Long-Term Adherence to Medication: Presented at ADA
100%DGNews: Insulin Therapy Lowers Haemoglobin Levels, but Most Patients Don't Reach Goal: Presented at ADA
100%DGNews: FDA Approves Cabazitaxel for Metastatic Hormone-Refractory Prostate Cancer
100%DGNews: Study Affirms Benefit of Cabazitaxel in Castration-Resistant Prostate Cancer: Presented at ASCO
100%DGNews: Cetuximab Does Not Improve Survival in Resected Colon Cancer Cases Where KRAS Gene Is Present: Presented at ASCO
100%DGNews: Addition of Irinotecan to Cisplatin/Docetaxel Provides No Benefit in NSCLC, More Severe Toxicities: Presented at ASCO
100%DGNews: Pegylated Liposomal Doxorubicin May Be a First-Line Alternative to Capecitabine in Metastatic Breast Cancer: Presented at ASCO
100%DGNews: Prognostic Marker Assessment for Early Breast Cancer Patients Reveals Discordance: Presented at ASCO
95%DGNews: FDA Approves Preservative-Free Influenza Vaccine for Paediatric Use
95%DGNews: FDA Approves Once-Daily Lantus (Insulin Glargine) For Diabetes
94%DGNews: FDA Grants Approvable Letter for Alvesco (ciclesonide) for Treatment of Persistent Asthma
94%DGNews: FDA Gives Approvable Letter For Ketek (Telithromycin) Tablets For Treatment Of Community-Acquired Respiratory Tract Infections
94%DGNews: Advisory Panel Recommends FDA Approval Of Ketek (Telithromycin) For Treatment Of Respiratory Tract Infections
93%DGNews: Voluntary Recall of One Lot of FluoticŪ (sodium fluoride) 20 mg tablets and Notice of Product Discontinuation
93%DGNews: FDA Approves New Allegra (Fexofenadine) Dosage For Allergic Rhinitis
93%DGNews: Clinical Study Shows The Combination Therapy Benzamycin Out-Performs 0.025% Tretinoin/4% Erythromycin In The Treatment Of Facial Acne
93%DGNews: FDA Approves Actonel (Risedronate) For Once-A-Week Use
93%DGNews: New Data Show Exubera Patients With Type 1 Diabetes Reach Recommended Blood Glucose Levels Equal to Insulin Injections
93%DGNews: Safety Alert: Patients Taking Arava (Leflunomide) for Rheumatoid Arthritis Asked to Take Precautions Against Liver Injury
93%DGNews: Vaxigrip And Fluzone Flu Vaccines Not Associated With Reported Adverse Events In Canada
93%DGNews: Synercid (Quinupristin/Dalfopristin), Antibiotic For Severe Infections, Available In Canada
92%DGNews: FDA Approves Taxotere (Docetaxel) For First-Line Treatment Of Non-Small Cell Lung Cancer
92%DGNews: Women In Landmark Canadian Cardiovascular Study Fare As Well As Men
92%DGNews: Aventis Launches Ketek (Telithromycin) in France
92%DGNews: Combination Therapy Reduces Acne-Causing Bacteria by 90 Percent After One Day; Study Published in the Journal Cutis Shows Unprecedented Results
92%DGNews: ADA: Exubera (Inhaled Insulin) Provides Better Glycemic Control Than Oral Therapy For Patients With Type 2 Diabetes, New Data Show
92%DGNews: Germany Approves Delix (Ramipril) for Stroke/Heart Attack Prevention
92%DGNews: FDA Grants Fast Track Review For Emphysema Treatment Candidate
92%DGNews: Arava (Leflunomide) Launched In Canada For Rheumatoid Arthritis
92%[Replication or Save Conflict]
92%DGNews: Gammar-PIV Immune Globulin Indicated In U.S. For Adolescents And Children With Primary Immune Deficiency
92%DGNews: FDA Approves Actonel (Risedronate) For Osteoporosis
91%DGNews: Sanofi-aventis Received from the FDA an Approvable Letter for Rimonabant for Weight Management and a Non Approvable Letter for Smoking Cessation
91%DGNews: Advisory Panel Recommends FDA Licensure of Menactra Vaccine for Protection Against Meningococcal Disease
91%DGNews: FDA Approves OptiClik(TM), New Insulin Pen System from Aventis
91%DGNews: FDA Approves Ketek (Telithromycin) Tablets
91%DGNews: FDA Approves Flexible Administration Schedule For Lantus (Insulin Glargine [rDNA Origin] Injection)
91%DGNews: FDA Advisory Committee Recommends Arava (Leflunomide) For Improvement In Physical Function In Rheumatoid Arthritis
91%DGNews: ENDO: Bone Microarchitecture Can Significantly Deteriorate In One Year In Early Postmenopausal Women, Despite Only Modest Bmd Loss
91%DGNews: ECCMID: Ketek Shown To Be More Active Than Commonly Used Antibiotics In Children With Community-Acquired Respiratory Tract Infections
91%DGNews: ECCMID: Ketek Shown To Be More Active Than Commonly Used Antibiotics In Children With Community-Acquired Respiratory Tract Infections
91%DGNews: ECCMID: KetekŪ (Telithromycin) Shown To Be More Effective Than Other Commonly Used Antibiotics
91%DGNews: ECCMID: Once Daily Ketek As Safe And Effective As Levofloxacin Three Times Daily In Treating Patients With Community Acquired Pneumonia (Cap)
91%DGNews: Europe Grants Orphan Drug Status to Alpha1-Antitrypsin for Hereditary Emphysema
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.